TABLE 4.
Univariate Analysis for immune status before the third vaccine vs. post third vaccine in RTR.
| Before 3rd vaccine (N = 99) | Post 3rd vaccine (N = 99) | p value | |
|---|---|---|---|
| All cohort | |||
| IgG-RBD GMT (95% CI) | 0.79 (0.65–0.96) | 3.08 (2.76–3.45) | <0.0001** |
| NA GMT (95% CI) | 17.46 (12.38–24.62) | 362.2 (220.7–594.6) | <0.0001** |
| Positive responders | |||
| n (%) | 32 (32.3) | 85 (85.9) | <0.0001** |
| IgG-RBD GMT (95% CI) | 2.53 (2.07–3.11) | 3.57 (3.28–3.88) | <0.0001** |
| NA GMT (95% CI) | 89.12 (53.03–149.8) | 689.9 (456.3–1043) | <0.0001** |
| Negative responders | |||
| n (%) | 67 (67.7) | 14 (14.14) | <0.0001** |
| IgG-RBD GMT (95% CI) | 0.45 (0.39–0.52) | 1.28 (0.87–1.86) | 0.001* |
| NA GMT (95% CI) | 8.01 (5.92–10.84) | 7.25 (2.42–21.71) | 0.85 |
Abbreviations: CI, confidence intervals; GMT, geometric mean titer; NA, neutralizing antibodies; RBD, receptor-binding domain.
* <0.05, ** <0.001.
When p value is significant, below 0.05 or below 0.01 the values are bolded.